ヒト胚性幹細胞の世界市場レポート 2024年

ヒト胚性幹細胞市場規模は、今後数年で急成長が見込まれます。2028年にはCAGR10.3％で18億3,000万米ドルに成長します。予測期間の成長急増は、細胞治療生産施設の増加、再生治療に対する需要の高まり、心疾患や悪性疾患の有病率の増加、幹細胞生物学研究の進展、幹細胞の治療可能性に対する認識の高まりなど、様々な要因に関連しています。この期間に予想される注目すべき動向には、再生医療の進展、個別化医療の重視の高まり、創薬や毒性学における応用の拡大、技術の進歩、バイオバンクの拡大などが含まれます。

再生医療開発のための政府資金は、ヒト胚性幹細胞市場の成長を促進すると予想されます。再生医療は、損傷した組織や臓器を修復したり置き換えたりすることで、正常な身体機能を回復させることを目的としています。この分野は、慢性疾患の蔓延や幹細胞研究の進歩などの要因により、政府からの支援が増加しています。ヒト胚性幹細胞は、組織や臓器の修復のための潜在的な治療法を提供することで、再生医療において重要な役割を果たしています。例えば、カナダ政府は2022-23年からの3年間で、幹細胞と再生医療の研究を強化するために4,500万米ドルを割り当て、この分野への強いコミットメントを示しています。

ヒト胚性幹細胞市場の大手企業は、競争上の優位性を獲得するため、パーキンソン病治療のための多能性幹細胞など、多様な治療用途に焦点を広げています。多能性幹細胞にはドーパミン作動性ニューロンを生成する可能性があり、失われたドーパミン産生ニューロンを補うことで運動機能を回復させることができます。2023年10月、バイエルAGは2億5,000万米ドルを投資し、カリフォルニア州に初の細胞治療製造施設を設立しました。当初は、パーキンソン病治療を目的としたブルーロック・セラピューティクス社の多能性幹細胞由来ベムダネプロセルをターゲットとします。この施設は完全電動製造能力を備えており、再生医療製造能力の向上に対する業界のニーズに応えるものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界のヒト胚性幹細胞市場：促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界のヒト胚性幹細胞市場の実績：規模と成長、2018年～2023年
• 世界のヒト胚性幹細胞市場の予測：規模と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のヒト胚性幹細胞市場：タイプ別、実績と予測、2018年～2023年、2023年～2028年、2033年
• 全能性幹細胞
• 多能性幹細胞
• 単能性幹細胞
• 世界のヒト胚性幹細胞市場：製品別、実績と予測、2018年～2023年、2023年～2028年、2033年
• 再生医療
• 幹細胞生物学調査
• ヒト組織工学
• 毒性試験
• 世界のヒト胚性幹細胞市場：用途別、実績と予測、2018年～2023年、2023年～2028年、2033年
• 研究
• 臨床試験
• その他の用途

第7章 地域別・国別分析

• 世界のヒト胚性幹細胞市場：地域別、実績と予測、2018年～2023年、2023年～2028年、2033年
• 世界のヒト胚性幹細胞市場：国別、実績と予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ヒト胚性幹細胞市場：競合情勢
• ヒト胚性幹細胞市場：企業プロファイル
  • Thermo Fisher Scientific Inc.
  • Takeda Pharmaceutical Company Limited
  • Gilead Sciences Inc.
  • Merck KgaA
  • Astellas Pharma Inc.

第31章 その他の大手企業と革新的企業

• Lonza Group
• PerkinElmer Inc.
• R&D Systems
• LifeCell
• Takara Bio Inc.
• ViaCyte Inc.
• PromoCell GmbH
• CellGenix GmbH
• PeproTech Inc.
• Lineage Cell Therapeutics Inc.
• BioTime
• Asterias Biotherapeutics Inc.
• ESI BIO
• STEMCELL Technologies Inc.
• TATAA Biocenter

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

Human embryonic stem cells (hESCs) are pluripotent cells derived from the inner cell mass of a blastocyst, an early-stage embryo. These cells possess the remarkable capability to differentiate into any cell type in the human body, making them immensely valuable for various research and therapeutic applications. The primary uses of hESCs include developing treatments for diseases and injuries by generating healthy tissue and studying disease progression and treatment in a controlled environment.

The main types of human embryonic stem cells are totipotent stem cells, pluripotent stem cells, and unipotent stem cells. Totipotent stem cells can differentiate into any cell type found in an embryo, including extra-embryonic tissues such as the placenta. The products derived from hESCs find applications in regenerative medicine, stem cell biology research, tissue engineering, and toxicology testing. These applications span across research, clinical trials, and other fields.

The human embryonic stem cells market research report is one of a series of new reports from The Business Research Company that provides human embryonic stem cells market statistics, including the human embryonic stem cells industry global market size, regional shares, competitors with the human embryonic stem cells market share, detailed human embryonic stem cells market segments, market trends, and opportunities, and any further data you may need to thrive in the human embryonic stem cells industry. These human embryonic stem cells market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The human embryonic stem cells market size has grown rapidly in recent years. It will grow from $1.13 billion in 2023 to $1.24 billion in 2024 at a compound annual growth rate (CAGR) of 10.1%. The growth observed in the historic period can be attributed to several factors, including increased funding and investments in stem cell research, regulatory approvals for research and clinical applications, heightened public awareness about stem cell therapies, the emergence of regenerative medicine as a field, and expanded clinical applications of stem cells in various medical treatments.

The human embryonic stem cells market size is expected to see rapid growth in the next few years. It will grow to $1.83 billion in 2028 at a compound annual growth rate (CAGR) of 10.3%. The surge in the forecasted period's growth can be linked to various factors, including the rise in cell therapy production facilities, heightened demand for regenerative therapies, increased prevalence of cardiac and malignant diseases, progress in stem cell biology research, and enhanced awareness of the therapeutic potential of stem cells. Notable trends expected during this period encompass progress in regenerative medicine, a heightened emphasis on personalized medicine, expanding applications in drug discovery and toxicology, technological advancements, and the expansion of biobanking.

Government funding for regenerative medicine development is anticipated to drive the growth of the human embryonic stem cells market. Regenerative medicine aims to restore normal bodily function by repairing or replacing damaged tissues or organs. This sector is receiving increased government support due to factors such as the growing prevalence of chronic diseases and advancements in stem cell research. Human embryonic stem cells play a crucial role in regenerative medicine by offering potential therapies for tissue and organ repair. For example, the Canadian government allocated $45 million over three years, starting in 2022-23, to bolster stem cell and regenerative medicine research, indicating a strong commitment to this field.

Major players in the human embryonic stem cell market are expanding their focus to include diverse therapeutic applications, such as pluripotent stem cells for treating Parkinson's disease, in order to gain a competitive advantage. Pluripotent stem cells have the potential to generate dopaminergic neurons, which can help restore motor function by replacing lost dopamine-producing neurons. In October 2023, Bayer AG invested $250 million to establish its first Cell Therapy Manufacturing Facility in California, initially targeting BlueRock Therapeutics' bemdaneprocel derived from pluripotent stem cells for Parkinson's disease treatment. This facility, equipped with fully electric manufacturing capabilities, addresses the industry's need for increased regenerative medicine manufacturing capacity.

In February 2024, Charles River Laboratories International Inc., a US-based pharmaceutical company, partnered with Pluristyx Inc. to enhance its portfolio with high-quality embryonic stem cells (ES) and induced pluripotent stem cells (iPSCs). This collaboration enables Charles River to distribute Pluristyx's extensive line of ES and iPSC cell lines, including genetically engineered and disease state lines, to support therapeutic development. Pluristyx Inc., a US-based stem cell technology company, specializes in providing human induced pluripotent stem cells (iPSCs).

Major companies operating in the human embryonic stem cells market are Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Merck KgaA, Astellas Pharma Inc., Lonza Group, PerkinElmer Inc., R&D Systems, LifeCell, Takara Bio Inc., ViaCyte Inc., PromoCell GmbH, CellGenix GmbH, PeproTech Inc., Lineage Cell Therapeutics Inc., BioTime, Asterias Biotherapeutics Inc., ESI BIO, STEMCELL Technologies Inc., TATAA Biocenter, Celgene Corporation

North America was the largest region in the human embryonic stem cells market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human embryonic stem cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the human embryonic stem cells market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The human embryonic stem cells market consists of sales of stem cell lines, stem cell media and reagents, and stem cell culture equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Human Embryonic Stem Cells Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on human embryonic stem cells market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for human embryonic stem cells ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The human embryonic stem cells market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Totipotent Stem Cells; Pluripotent Stem Cells; Unipotent Stem Cells
• 2) By Product: Regenerative Medicine; Stem Cell Biology Research; Tissue Engineering; Toxicology Testing
• 3) By Application: Research; Clinical Trials; Other Applications
• Companies Mentioned: Thermo Fisher Scientific Inc.; Takeda Pharmaceutical Company Limited; Gilead Sciences Inc.; Merck KgaA; Astellas Pharma Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Human Embryonic Stem Cells Market Characteristics

3. Human Embryonic Stem Cells Market Trends And Strategies

4. Human Embryonic Stem Cells Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Human Embryonic Stem Cells Market Size and Growth

• 5.1. Global Human Embryonic Stem Cells Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Human Embryonic Stem Cells Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Human Embryonic Stem Cells Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Human Embryonic Stem Cells Market Segmentation

• 6.1. Global Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Totipotent Stem Cells
• Pluripotent Stem Cells
• Unipotent Stem Cells
• 6.2. Global Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Regenerative Medicine
• Stem Cell Biology Research
• Tissue Engineering
• Toxicology Testing
• 6.3. Global Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Research
• Clinical Trials
• Other Applications

7. Human Embryonic Stem Cells Market Regional And Country Analysis

• 7.1. Global Human Embryonic Stem Cells Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Human Embryonic Stem Cells Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Human Embryonic Stem Cells Market

• 8.1. Asia-Pacific Human Embryonic Stem Cells Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Human Embryonic Stem Cells Market

• 9.1. China Human Embryonic Stem Cells Market Overview
• 9.2. China Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Human Embryonic Stem Cells Market

• 10.1. India Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Human Embryonic Stem Cells Market

• 11.1. Japan Human Embryonic Stem Cells Market Overview
• 11.2. Japan Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Human Embryonic Stem Cells Market

• 12.1. Australia Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Human Embryonic Stem Cells Market

• 13.1. Indonesia Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Human Embryonic Stem Cells Market

• 14.1. South Korea Human Embryonic Stem Cells Market Overview
• 14.2. South Korea Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Human Embryonic Stem Cells Market

• 15.1. Western Europe Human Embryonic Stem Cells Market Overview
• 15.2. Western Europe Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Human Embryonic Stem Cells Market

• 16.1. UK Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Human Embryonic Stem Cells Market

• 17.1. Germany Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Human Embryonic Stem Cells Market

• 18.1. France Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Human Embryonic Stem Cells Market

• 19.1. Italy Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Human Embryonic Stem Cells Market

• 20.1. Spain Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Human Embryonic Stem Cells Market

• 21.1. Eastern Europe Human Embryonic Stem Cells Market Overview
• 21.2. Eastern Europe Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Human Embryonic Stem Cells Market

• 22.1. Russia Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Human Embryonic Stem Cells Market

• 23.1. North America Human Embryonic Stem Cells Market Overview
• 23.2. North America Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Human Embryonic Stem Cells Market

• 24.1. USA Human Embryonic Stem Cells Market Overview
• 24.2. USA Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Human Embryonic Stem Cells Market

• 25.1. Canada Human Embryonic Stem Cells Market Overview
• 25.2. Canada Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Human Embryonic Stem Cells Market

• 26.1. South America Human Embryonic Stem Cells Market Overview
• 26.2. South America Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Human Embryonic Stem Cells Market

• 27.1. Brazil Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Human Embryonic Stem Cells Market

• 28.1. Middle East Human Embryonic Stem Cells Market Overview
• 28.2. Middle East Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Human Embryonic Stem Cells Market

• 29.1. Africa Human Embryonic Stem Cells Market Overview
• 29.2. Africa Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Human Embryonic Stem Cells Market Competitive Landscape And Company Profiles

• 30.1. Human Embryonic Stem Cells Market Competitive Landscape
• 30.2. Human Embryonic Stem Cells Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Takeda Pharmaceutical Company Limited
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Gilead Sciences Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Merck KgaA
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Astellas Pharma Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Human Embryonic Stem Cells Market Other Major And Innovative Companies

• 31.1. Lonza Group
• 31.2. PerkinElmer Inc.
• 31.3. R&D Systems
• 31.4. LifeCell
• 31.5. Takara Bio Inc.
• 31.6. ViaCyte Inc.
• 31.7. PromoCell GmbH
• 31.8. CellGenix GmbH
• 31.9. PeproTech Inc.
• 31.10. Lineage Cell Therapeutics Inc.
• 31.11. BioTime
• 31.12. Asterias Biotherapeutics Inc.
• 31.13. ESI BIO
• 31.14. STEMCELL Technologies Inc.
• 31.15. TATAA Biocenter

32. Global Human Embryonic Stem Cells Market Competitive Benchmarking

33. Global Human Embryonic Stem Cells Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Human Embryonic Stem Cells Market

35. Human Embryonic Stem Cells Market Future Outlook and Potential Analysis

• 35.1 Human Embryonic Stem Cells Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Human Embryonic Stem Cells Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Human Embryonic Stem Cells Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer